Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT05167084

Acute Consequences Of Food-induced Glucocorticoid Secretion In Healthy Individuals (Gluco-Feed)

Acute Consequences Of Food-induced Glucocorticoid Secretion In Healthy Individuals - A Double-blind, Randomized, Placebo-controlled Cross-over Study

Sponsor: Eleonora Seelig

Conditions Glucocorticoid Effect

Interventions Hydrocortisone 19,9mg s.c., pulsatile with a flow rate of 10μl/s Metyrapone 250 mg Oral Tablets Placebo (0,9% NaCl solution) Placebo 250 mg Tablets

Updated 6 times since 2022 Last updated: Aug 22, 2023 Started: Feb 8, 2022 Primary completion: Jun 8, 2023 Completion: Jun 8, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Glucocorticoid Effect, this trial is completed. The trial is conducted by Eleonora Seelig and has accumulated 6 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Sep 2023 — Jul 2024 [monthly]

Completed EARLY_PHASE1

Status: Recruiting → Completed
May 2022 — Sep 2023 [monthly]

Recruiting EARLY_PHASE1

Status: Not Yet Recruiting → Recruiting
Feb 2022 — May 2022 [monthly]

Not Yet Recruiting EARLY_PHASE1

▶ Show 1 earlier version

Jan 2022 — Feb 2022 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eleonora Seelig

Data source: University Hospital, Basel, Switzerland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Basel, Switzerland